Integration of questionnaire-based risk factors improves polygenic risk scores for human coronary heart disease and type 2 diabetes

Max Tamlander(University of Helsinki), Jeffrey Waring(Boehringer Ingelheim (Germany)), Robert Graham(GenProMarkers (United States)), Anne Pitkäranta, Antti Hakanen, Deepak Raipal, Jukka Partanen(Finnish Red Cross), George Okafo, Dirk S. Paul(AstraZeneca (United Kingdom)), Simonne Longerich, Tarja Laitinen(Tampere University), Tomi P. Mäkelä(University of Helsinki), Raimo Pakkanen, Markus Perola(Broad Institute), Juhani Junttila(Oulu University Hospital), Outi Tuovila, Nina Mars(Broad Institute), Bridget Riley-Gills, Matti Pirinen(Broad Institute), Mark I. McCarthy(Centre for Human Genetics), Raisa Serpi, Howard J. Jacob(Medical College of Wisconsin), Terhi Kilpi(Finnish Institute for Health and Welfare), Aarno Palotie(Broad Institute), Heiko Runz(Heidelberg University), Joseph Maranville(Finnish Institute for Health and Welfare), Chris O’Donnell, Eric Green(Janssen (Belgium)), Anders Mälarstig, Marco Hautalahti, Jari Laukkanen, Robert M. Plenge, Mark J. Daly(Broad Institute), Caroline S. Fox(Boston University), Meg Ehm(Merck & Co., Inc., Rahway, NJ, USA (United States)), Robert Yang, Julie Hunkapiller, Veli‐Matti Kosma(University of Eastern Finland), Sally John, Nathan Lawless, Kirsi Auro(University of Helsinki), Katherine Klinger, Arto Mannermaa(University of Eastern Finland), Heli Salminen‐Mankonen, Petri Virolainen, Jaakko Kaprio(University of Helsinki)
Communications Biology
February 23, 2022
Cited by 51


Related Papers